Browse studies

Find your next paid study

8 recruiting studies matching your filters

Augmenting Parent Management Training With Naturalistic Skills for Child Temper Outbursts Using a Digital Tool

Background: Pediatric disruptive behavior disorders (DBDs) are characterized by severe irritability, anger, and temper outbursts. The primary way to treat chi…

Disruptive Behavior DisordersConduct DisorderOppositional Defiant Disorder+1 more

Estimated

~$10 – $675

National Institute of Mental Health (NIMH)NCT07764536

Observational

Effects of Binaural Beats Stimulation on Attention and Memory in Adults With Attention-Deficit/Hyperactivity Disorder

This study is conducted entirely in person at California State University, San Bernardino. Participation requires 12 campus visits over six weeks. Remote parti…

Attention-Deficit/Hyperactivity Disorder (ADHD)

Estimated

~$10 – $6,250

California State University, San BernardinoNCT07793045

Phase 4

Comparing Medication Treatments for Neurodevelopmental Differences in Young Children on Rates of Beneficial Response

This project will evaluate the effectiveness of Methylphenidate versus Guanfacine in treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged …

Attention-Deficit/Hyperactivity Disorder (ADHD)

Estimated

~$10 – $5,625

Children's Hospital Medical Center, CincinnatiNCT07300956

Phase 3

A Phase 3b, Multicenter, Open-label, Single-arm Trial to Evaluate the Efficacy and Safety of Orally Administered Centanafadine QD XR Capsules in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation

The primary purpose of this study is to evaluate the efficacy of centanafadine once daily (QD) extended-release (XR) capsules in adults with attention-deficit/…

Attention-deficit/Hyperactivity DisorderEmotional Dysregulation

Estimated

~$10 – $8,750

Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07759154

Phase 4

A Phase 4, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of SPN-812 in Preschool-Age Children (4 to 5 Years Old) With Attention-Deficit/Hyperactivity Disorder (ADHD)

This study will evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD.

Attention-Deficit/Hyperactivity Disorder

Estimated

~$10 – $8,750

Supernus Pharmaceuticals, Inc.NCT04781140

Phase 2

CBG and Attention: A Double-Blind, Randomized, Placebo-Controlled Trial Examining the Effects of Cannabigerol on Indicators of Attention-Deficit/Hyperactivity Disorder

The goal of this clinical trial is to evaluate the effects of Cannabigerol (CBG) on indicators of Attention-Deficit/Hyperactivity Disorder (ADHD) in a sample o…

Attention-Deficit/Hyperactivity Disorder

Estimated

~$10 – $6,250

University of Arkansas, FayettevilleNCT06115603

Phase 4

An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening

The goal of this study is to extend the efficacy evidence of sustained release methylphenidate compound (JornayPM) in adults with Attention-deficit/hyperactivi…

Attention-deficit/Hyperactivity Disorder

Estimated

~$10 – $7,500

NYU Langone HealthNCT06577779

Observational

A Pilot Study of a Remote Attention-Deficit/Hyperactivity Disorder Monitoring Program (RAMP) for Children in Rural Areas

RAMP is a pilot study examining the use of an Attention-Deficit/Hyperactivity Disorder (ADHD) Monitoring Program during the early stages of treating ADHD in ch…

Attention-deficit/Hyperactivity DisorderADHD

Estimated

~$10 – $6,250

IDeA States Pediatric Clinical Trials NetworkNCT06743425